Abstract
Angiogenesis plays an important role in airway remodeling that occurs in asthma, while the mechanisms underlying this process are not fully elucidated. Found in inflammatory zone 1 (FIZZ1), a novel cysteine-rich secreted protein, is able to promote proliferation and migration of pulmonary endothelial cells, and to upregulate the expression of vascular endothelial growth factor (VEGF). However, the role of FIZZ1 in angiogenesis of asthma has not been fully investigated. Murine models of asthma were sensitized on days 1 and 14 by ovalbumin (OVA) and challenged with 2% OVA beginning from day 21. Mice were divided into four groups: asthmatic mice challenged with OVA for 7 days, 14 days, and 28 days, respectively, and healthy control mice that were sensititized and challenged with PBS. The expressions of FIZZ1, VEGF, and von Willebrand factor (vWF)-stained vascular area were measured in asthmatic mice and healthy controls (n = 10). Histologic examination was also performed on airway inflammation. Levels of FIZZ1 were increased significantly after allergic challenge, reached the peak by 7 days, declined by 14 days, and were reduced further by 28 days after OVA challenge. Similarly, percentages of vWF-stained vascular area (percentage of vascularity) were largely increased within 7 days and then reduced from day 14 of challenge. The expression of FIZZ1 in asthma was positively correlated with vWF-stained vascular area and VEGF expression in a time-dependent manner. FIZZ1 expression was significantly correlated with the percentage of vascularity and VEGF expression, suggesting that FIZZ1 and VEGF have crucial roles in angiogenesis of asthma.
Similar content being viewed by others
References
Asosingh K, Swaidani S, Aronica M, Erzurum SC (2007) Th1- and Th2-dependent endothelial progenitor cell recruitment and angiogenic switch in asthma. J Immunol 178:6482–6494
Mohsenin A, Burdick MD, Molina JG, Keane MP, Blackburn MR (2007) Enhanced CXCL1 production and angiogenesis in adenosine-mediated lung disease. FASEB J 21:1026–1036. doi:10.1096/fj.06-7301com
Renigunta A, Hild C, Rose F, Klepetko W, Grimminger F, Seeger W, Hanze J (2006) Human RELMbeta is a mitogenic factor in lung cells and induced in hypoxia. FEBS Lett 580:900–903. doi:10.1016/j.febslet.2006.01.012
Nair MG, Cochrane DW, Allen JE (2003) Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro. Immunol Lett 85:173–180. doi:10.1016/S0165-2478(02)00225-0
Raes G, De Baetselier P, Noël W, Beschin A, Brombacher F, Hassanzadeh GG (2002) Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J Leukoc Biol 71:597–602
Teng X, Li D, Champion HC, Johns RA (2003) FIZZ1/RELMalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties. Circ Res 92:1065–1067. doi:10.1161/01.RES.0000073999.07698.33
Tong Q, Zheng L, Li B, Wang D, Huang C, Matuschak GM, Li D (2006) Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells. Exp Cell Res 312:3559–3569. doi:10.1016/j.yexcr.2006.07.024
Styer AK, Sullivan BT, Puder M, Arsenault D, Petrozza JC, Serikawa T, Chang S, Hasan T, Gonzalez RR, Rueda BR (2008) Ablation of leptin signaling disrupts the establishment, development and maintenance of endometriosis-like lesions in a murine model. Endocrinology 149:506–514. doi:10.1210/en.2007-1225
Moody DM, Thore RC, Anstrom JA, Challa VR, Langefeld CD, Brown WR (2004) Quantification of afferent vessels shows reduced brain vascular density in subjects with leukoaraiosis. Radiology 233:883–890. doi:10.1148/radiol.2333020981
Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV Jr, Shelton DL, Hébert CC (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19:4046–4055. doi:10.1093/emboj/19.15.4046
Tang Q, Zheng L, Lin L, Li B, Wang D, Huang C, Li D (2006) VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-kappaB signaling pathway. Respir Res 7:37. doi:10.1093/emboj/19.15.4046
Yamaji-Kegan K, Su Q, Angelini DJ, Champion HC, Johns RA (2006) Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol 291:L1159-L1168. doi:10.1152/ajplung.00168.2006
Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger D (1995) Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107:233–235
Hoshino M, Nakamura Y, Hamid QA (2001) Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 107:1034–1038. doi:10.1067/mai.2001.115626
McDonald DM (2001) Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 164:S39–S45
Baluk P, Lee CG, Link H, Ator E, Haskell A, Elias JA, McDonald DM (2004) Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. Am J Pathol 165:1071–1085
Acknowledgments
This work has received financial assistance from a Chinese National Research Grant.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, Y., Wang, J., Li, H. et al. Found in Inflammatory Zone 1 Induces Angiogenesis in Murine Models of Asthma. Lung 186, 375–380 (2008). https://doi.org/10.1007/s00408-008-9099-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-008-9099-1